NDC 61314-625 – Cimerli
Ranibizumab .5 mg/.05mL · Injection, Solution · Intravitreal
Product NDC61314-625
Product details
- Brand name
- Cimerli
- Generic name
- Ranibizumab-eqrn
- Labeler
- Sandoz Inc
- Dosage form
- Injection, Solution
- Route
- Intravitreal
- Marketing category
- BLA · BLA761165
- Marketed since
- December 12, 2024
- Listing expires
- December 31, 2026
- Pharmacologic class
- Vascular Endothelial Growth Factor Inhibitor
Active ingredients
- Ranibizumab .5 mg/.05mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 61314-625-94 | 1 VIAL, SINGLE-DOSE in 1 CARTON (61314-625-94) / .05 mL in 1 VIAL, SINGLE-DOSE | Dec 12, 2024 |